Literature DB >> 9491808

Transcription factor NF-kappaB: friend or foe of neurons?

F Lezoualc'h1, C Behl.   

Abstract

It is now well established that a number of neurological disorders such as Parkinson's disease and Alzheimer's disease are characterized by the formation of reactive oxygen species (ROS). When produced in excess, ROS can induce oxidative damage to cellular macromolecules and ultimately cell death. Cells 'employ a number of defense systems against oxidative damage, including antioxidants and antioxidant enzymes. In an effort to develop a better understanding of the molecular mechanisms of the cellular response to a challenge by ROS as observed under certain neuropathological conditions, recent studies have focused on the regulation of gene expression by neurotoxins, including oxidative stressors. One transcription factor that can be activated by oxidative stress is the nuclear transcription factor-kappa B (NF-kappaB). Initially, this factor has been shown to play a major role in the activation of defensive genes during immune and inflammatory responses. But as evidence accumulates suggesting a close association of NF-kappaB activation also with the neuropathology occurring in neurodegenerative processes and neuronal cell death, the search is on to define potential roles for this transcription factor that are specific for neurons. The present article summarizes some of the recent studies that are trying to clarify NF-kappaB's role during neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491808     DOI: 10.1038/sj.mp.4000295

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  11 in total

1.  Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures.

Authors:  Ella Kratsovnik; Yael Bromberg; Oded Sperling; Esther Zoref-Shani
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders.

Authors:  M A Altinoz; B Ince; C Tek; V H Srihari; S Guloksuz
Journal:  Mol Psychiatry       Date:  2016-11-15       Impact factor: 15.992

3.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure.

Authors:  P J Lucassen; M B Müller; F Holsboer; J Bauer; A Holtrop; J Wouda; W J Hoogendijk; E R De Kloet; D F Swaab
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  Disruption of neurogenesis by hypothalamic inflammation in obesity or aging.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

Review 5.  Neuroinflammation in overnutrition-induced diseases.

Authors:  Dongsheng Cai
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

6.  Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

Authors:  A Post; F Holsboer; C Behl
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

7.  Down-regulation of ROCK2 alleviates ethanol-induced cerebral nerve injury partly by the suppression of the NF-κB signaling pathway.

Authors:  Xinguo Li; Jing Tong; Jihui Liu; Yibao Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 8.  Inflammatory cause of metabolic syndrome via brain stress and NF-κB.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Aging (Albany NY)       Date:  2012-02       Impact factor: 5.682

9.  Maf1 Ameliorates Sepsis-Associated Encephalopathy by Suppressing the NF-kB/NLRP3 Inflammasome Signaling Pathway.

Authors:  Shenglong Chen; Chaogang Tang; Hongguang Ding; Zhonghua Wang; Xinqiang Liu; Yunfei Chai; Wenqiang Jiang; Yongli Han; Hongke Zeng
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

10.  Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease.

Authors:  Philip Wl Ho; Jessica Wm Ho; Hui-Fang Liu; Danny Hf So; Zero Hm Tse; Koon-Ho Chan; David B Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2012-01-13       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.